New York's attorney general plans to announce a settlement with U.S. units of Ranbaxy and Teva over allegations the generic drug makers made an unlawful agreement to restrict competition.
via WSJ.com: US Business http://ift.tt/1ja05ds
via WSJ.com: US Business http://ift.tt/1ja05ds
Nessun commento:
Posta un commento